Seasonal trivalent influenza vaccine for 2009-2010

Medical Letter on Drugs and Therapeutics

Volumn 51, Issue 1321, 2009, Pages 73-74

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EGG PROTEIN; FLUANIX; FLULAVAL; INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; TRIPLE VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; DRUG EFFICACY; DRUG FORMULATION; GUILLAIN BARRE SYNDROME; HIGH RISK POPULATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INJECTION SITE REACTION; NOSE CONGESTION; PANDEMIC; REPEATED DRUG DOSE; RHINORRHEA; SHORT SURVEY; SINGLE DRUG DOSE; SORE THROAT; VIRUS SHEDDING; VIRUS STRAIN; VIRUS TRANSMISSION; ARTICLE; ECONOMICS; RISK FACTOR; TIME;

HUMANS; INFLUENZA VACCINES; RISK FACTORS; TIME FACTORS;

EID: 70349782426     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. Update: Influenza Activity - United States, April-August 2009. MMWR Morbid Mortal Wkly Rep 2009; 58 (Early Release):1.
2. K Hancock et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:epub.
3. AE Fiore et al. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Morbid Mortal Wkly Rep 2008; 58 (RR08):1.
4. Receipt of influenza vaccine during pregnancy among women with live births - Georgia and Rhode Island, 2004-2007. MMWR Morbid Mortal Wkly Rep 2009; 58:972.
5. KL Nichol et al. Effectiveness of influenza vaccine in the community- dwelling elderly. N Engl J Med 2007; 357:1373.
6. DM Skowronski. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J Infect Dis 2008; 197:490.
7. MJ Gaglani et al. Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children. Arch Pediatr Adolesc Med 2004; 158:65.
8. DM Fleming et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2006; 25:860.
9. RB Belshe et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007; 356:685.
10. SE Ohmit et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006; 355:2513.
11. SE Ohmit et al. Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. J Infect Dis 2008; 198:312.
12. Z Wang et al. Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel. JAMA 2009; 301:945.
13. P Haber et al. Vaccines and Guillain-Barré syndrome. Drug Saf 2009; 32:309.